Topic specific news, updated constantly
from the most reliable sources, all in one place.
Other NewsOnly
Information Pages
Information Pages
Dr. Kimberly Parks Connects With Patient on Boston Med - Vitals Spotlight
Dr. Kimberly Parks Connects With Patient on Boston Med Vitals Spotlight (abcnews.go.com) Pollet had been diagnosed with since 2008 and has had to live each day like it was his last. Amyloidosis is a “disorder in ... New ABC series 'Boston Med' has heart 'Boston Med' Reaches an Emotional Ending (VIDEO) As a Doctor Works to Find Her Patient a Heart, Her Bond to His Family Grows ... |
Celebrating 40 Years in 2010 - Profound benefits for a wide range of health ... - PR Newswire (press release)
Celebrating 40 Years in 2010 - Profound benefits for a wide range of health ... PR Newswire (press release) Samantha Albert of Stratford, Ontario, says they help her deal with the effects of a critical blood disorder called . Helen Gaunt a wine producer ... |
Alnylam to Webcast Conference Call Discussing Second Quarter 2010 Financial ... - MarketWatch (press release)
Alnylam to Webcast Conference Call Discussing Second Quarter 2010 Financial ... MarketWatch (press release) ... including respiratory syncytial virus (RSV), liver cancers, TTR-mediated (ATTR), hypercholesterolemia, and Huntington's disease. ... |
Chip Miller Surf Fest splashes into Ocean City - Shore News Today
Chip Miller Surf Fest splashes into Ocean City Shore News Today All proceeds are donated to the Chip Miller Charitable Foundation, whose mission is to empower people with the knowledge and understanding of ... |
Diffuse Fatty Infiltration of the Thyroid Gland in - Journal of Ultrasound in Medicine (subscription)
Diffuse Fatty Infiltration of the Thyroid Gland in Amyloidosis Journal of Ultrasound in Medicine (subscription) It might be accompanied by amyloid deposition and can rarely be seen in patients with primary systemic . 3 , 5 We report diffuse fatty ... |
Alnylam Initiates Dosing in Phase I Clinical Study of ALN-TTR01 in Patients ... - MarketWatch (press release)
Alnylam Initiates Dosing in Phase I Clinical Study of ALN-TTR01 in Patients ... MarketWatch (press release) The study is aimed at evaluating the safety and tolerability of ALN-TTR01 in patients with transthyretin (TTR)-mediated (ATTR), ... Tekmira's Partner Alnylam Initiates Dosing in a Phase 1 Clinical Trial of ALN ... Alnylam Initiates Dosing In Phase I ALN-TTR01 Study In Transthyretin-Mediated ... Alnylam launches rare-disease trial |
Support, interest remains high for Chip Miller Surf Fest in 7th year - Press of Atlantic City
Support, interest remains high for Chip Miller Surf Fest in 7th year Press of Atlantic City The event honors Chip Miller of Ocean City, who suffered from a rare disease called and died in 2004. Amyloidosis degenerates the body's organs ... |
Alnylam to Webcast Virtual RNAi Roundtable on ALN-TTR for Treatment of ... - MarketWatch (press release)
Alnylam to Webcast Virtual RNAi Roundtable on ALN-TTR for Treatment of ... MarketWatch (press release) ... RNAi Roundtable to discuss ALN-TTR for the treatment of transthyretin (TTR)-mediated (ATTR) on Thursday, July 22, 2010 at 2:00 pm ET. ... |
Despite fears, proper estate planning vital for loved ones' future - Boston Herald
Despite fears, proper estate planning vital for loved ones' future Boston Herald On May 31, he was diagnosed with a condition called primary , a rare, unforgiving, unrelenting disease that attacked him everywhere, ... |
Weather shortens but doesn't ruin Chip Miller Surf Fest - Press of Atlantic City
Weather shortens but doesn't ruin Chip Miller Surf Fest Press of Atlantic City Chip, an Ocean City surfing dad, died in 2004 of , a rare disease that cannot be cured but can be treated. The Surf Fest raises money for ... ANNUAL SURF FEST DRAWS PLENTY TO OC FOR A GOOD CAUSE Thunderstorm cuts Chip Miller Surf Fest short |